Recombinant IL5RA (Benralizumab Biosimilar) antibody
The Mammalian Cells Monoclonal anti-IL5RA (Benralizumab Biosimilar) antibody (ABIN7487950) specifically detects IL5RA (Benralizumab Biosimilar) in ELISA.
The antibody is reactive with Human samples.
Catalog No. ABIN7487950
$323.13
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 10 Business Days
Quick Overview for Recombinant IL5RA (Benralizumab Biosimilar) antibody (ABIN7487950)
Target
IL5RA (Benralizumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Mammalian Cells
Clonality
Monoclonal
Conjugate
This IL5RA (Benralizumab Biosimilar) antibody is un-conjugated
Application
ELISA
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Benralizumab Biosimilar - Anti-IL5RA, CD125 mAb
-
Characteristics
- Antibody Type: IgG1-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotype
- IgG1 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS pH 7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- IL5RA (Benralizumab Biosimilar)
-
Target Type
- Biosimilar
-
Background
-
BIW-8405,KHK4563,MEDI-563
Benralizumab is a monoclonal antibody medication which is developed for the treatment of asthma. It is directed against the alpha-chain of the interleukin-5 receptor (CD125). -
CAS-No
- 1044511-01-4
Target
-
You are here:
